Hoth Therapeutics (HOTH) Stock Chart & Stock Price History → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free HOTH Stock Alerts $1.16 -0.04 (-3.33%) (As of 04/22/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Hoth Therapeutics Stock Price Performance5 Day Performance-1.69%1 Month Performance-22.67%3 Month Performance-9.38%6 Month Performance-12.12%Year-To-Date Performance-19.44%1 Year Performance-42.00% Receive HOTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hoth Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. HOTH Stock Chart for Tuesday, April, 23, 2024 HOTH Chart by TradingView Hoth Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$1.20$1.16-2.97%$1.23$1.1515,020 shs$5.67 million04/19/2024$1.18$1.16-1.69%$1.23$1.1622,183 shs$5.67 million04/18/2024$1.23$1.18-4.07%$1.23$1.1719,550 shs$5.77 million04/17/2024$1.22$1.23+0.82%$1.26$1.1623,588 shs$6.02 million04/16/2024$1.19$1.22+2.52%$1.26$1.1575,453 shs$5.97 million04/15/2024$1.22$1.19-2.46%$1.27$1.1955,043 shs$5.24 million Get the Latest News and Ratings for HOTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hoth Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$1.26$1.22-3.17%$1.31$1.2228,084 shs$5.37 million04/11/2024$1.26$1.26$1.32$1.2238,608 shs$5.55 million04/10/2024$1.28$1.26-1.56%$1.32$1.2167,571 shs$5.54 million04/09/2024$1.34$1.28-4.48%$1.37$1.2549,565 shs$5.63 million04/08/2024$1.40$1.34-4.29%$1.40$1.2964,737 shs$5.90 million04/05/2024$1.43$1.40-2.10%$1.45$1.3563,344 shs$6.16 million04/04/2024$1.42$1.43+0.70%$1.45$1.4037,252 shs$6.29 million04/03/2024$1.37$1.42+3.65%$1.43$1.3560,362 shs$6.25 million04/02/2024$1.42$1.37-3.52%$1.47$1.35143,030 shs$5.96 million04/01/2024$1.52$1.42-6.58%$1.49$1.35311,900 shs$6.17 million03/29/2024$1.52$1.52$1.52$1.36255,258 shs$6.61 million03/28/2024$1.38$1.52+10.14%$1.52$1.36254,519 shs$6.61 million03/27/2024$1.49$1.38-7.38%$1.59$1.303.25 million shs$6.00 million03/26/2024$1.52$1.49-1.97%$1.53$1.4969,479 shs$6.48 million03/25/2024$1.50$1.52+1.33%$1.60$1.50149,679 shs$6.61 million03/22/2024$1.65$1.50-9.09%$1.64$1.50265,099 shs$6.53 million03/21/2024$1.46$1.65+13.01%$1.65$1.37636,425 shs$7.17 million03/20/2024$1.35$1.46+8.15%$1.49$1.341.04 million shs$6.35 million03/19/2024$1.15$1.35+17.39%$1.67$1.2219.54 million shs$5.87 million03/18/2024$1.16$1.15-0.86%$1.21$1.1526,076 shs$5.00 million03/15/2024$1.16$1.16$1.25$1.1639,341 shs$5.05 million03/14/2024$1.17$1.16-0.85%$1.20$1.1638,915 shs$5.05 million03/13/2024$1.25$1.17-6.40%$1.28$1.1757,856 shs$5.09 million03/12/2024$1.30$1.25-3.85%$1.31$1.2515,665 shs$5.44 million03/11/2024$1.30$1.30$1.35$1.2925,399 shs$5.66 million03/08/2024$1.29$1.30+1.17%$1.30$1.274,224 shs$5.66 million03/07/2024$1.31$1.29-1.91%$1.30$1.2614,204 shs$5.59 million03/06/2024$1.27$1.31+3.15%$1.32$1.2615,140 shs$5.70 million03/05/2024$1.28$1.27-0.39%$1.31$1.255,934 shs$5.52 million03/04/2024$1.34$1.28-4.85%$1.33$1.2543,557 shs$5.55 million03/01/2024$1.23$1.34+8.94%$1.34$1.3040,582 shs$5.83 million02/29/2024$1.27$1.23-3.15%$1.33$1.23113,057 shs$5.35 million02/28/2024$1.27$1.27$1.32$1.2421,144 shs$5.52 million02/27/2024$1.30$1.27-2.31%$1.31$1.2623,594 shs$5.52 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.02/26/2024$1.30$1.30+0.39%$1.34$1.22309,725 shs$5.66 million02/23/2024$1.28$1.28$1.33$1.274,119 shs$5.57 million02/22/2024$1.35$1.28-5.19%$1.39$1.2645,804 shs$5.56 million02/21/2024$1.37$1.35-1.46%$1.39$1.3313,093 shs$5.87 million02/20/2024$1.38$1.37-0.72%$1.40$1.357,842 shs$5.96 million02/19/2024$1.38$1.38$1.43$1.3620,400 shs$6.00 million02/16/2024$1.41$1.38-2.13%$1.43$1.3620,435 shs$6.00 million02/15/2024$1.35$1.41+4.44%$1.44$1.3826,202 shs$6.13 million02/14/2024$1.38$1.35-2.17%$1.41$1.3528,426 shs$5.87 million02/13/2024$1.37$1.38+0.73%$1.43$1.3626,873 shs$6.00 million02/12/2024$1.38$1.37-0.72%$1.43$1.3240,233 shs$5.95 million02/09/2024$1.37$1.40+2.19%$1.45$1.3858,713 shs$6.09 million02/08/2024$1.37$1.37$1.40$1.3410,318 shs$5.96 million02/07/2024$1.41$1.37-2.84%$1.42$1.3414,525 shs$5.96 million02/06/2024$1.35$1.41+4.44%$1.42$1.3433,525 shs$6.13 million02/05/2024$1.29$1.35+4.65%$1.46$1.3382,812 shs$5.87 million02/02/2024$1.33$1.30-2.26%$1.35$1.2512,514 shs$5.66 million02/01/2024$1.38$1.33-3.62%$1.37$1.3212,976 shs$5.79 million01/31/2024$1.37$1.38+0.73%$1.42$1.3516,108 shs$6.00 million01/30/2024$1.37$1.37$1.39$1.3328,774 shs$5.96 million01/29/2024$1.40$1.37-2.14%$1.44$1.3612,269 shs$5.96 million01/26/2024$1.31$1.39+6.11%$1.43$1.3072,134 shs$6.05 million01/25/2024$1.32$1.31-0.76%$1.35$1.2811,220 shs$5.70 million01/24/2024$1.28$1.32+3.13%$1.32$1.2825,601 shs$5.74 million01/23/2024$1.27$1.28+0.79%$1.30$1.2433,171 shs$5.57 million01/22/2024$1.29$1.27-1.55%$1.30$1.2233,832 shs$5.52 million Related Companies: Protagenic Therapeutics Stock Price Chart Vaccinex Stock Price Chart Avenue Therapeutics Stock Price Chart First Wave BioPharma Stock Price Chart Xenetic Biosciences Stock Price Chart Cadrenal Therapeutics Stock Price Chart Ainos Stock Price Chart Ayala Pharmaceuticals Stock Price Chart Oragenics Stock Price Chart Hillstream BioPharma Stock Price Chart Receive HOTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hoth Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HOTH) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.